Biocryst Pharmaceuticals buy Evercore Inc.
Start price
18.02.26
/
50%
€6.00
Target price
18.02.27
€14.35
Performance (%)
45.87%
Price
26.06.26
€8.75
Summary
This prediction is currently active. The BUY prediction by Evercore_Inc_ for Biocryst Pharmaceuticals has seen massive gains of 45.87%. This prediction currently runs until 18.02.27. The prediction end date can be changed by Evercore_Inc_ at any time. Evercore_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biocryst Pharmaceuticals | 11.604% | 11.604% |
| iShares Core DAX® | -1,36 % | -2,33 % |
| iShares Nasdaq 100 | -3,70 % | -1,24 % |
| iShares Nikkei 225® | -2,51 % | 6,91 % |
| iShares S&P 500 | -1,66 % | -0,64 % |
Comments by Evercore_Inc_ for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals (NASDAQ:BCRX) is now covered by analysts at Evercore Inc. They set an "outperform" rating and a $17.00 price target on the stock.
Ratings data for BCRX provided by MarketBeat